Ending soon: Get your first 3 months of STAT+ for $30 and access our exclusive coverage of CRISPR research

Stay up-to-date on key advances in CRISPR genome-editing technology. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

www.statnews.com/stat-plus World CRISPR Day Over the last decade, CRISPR has been used to manipulate the genomes of organisms across every branch of the tree of life, including humans. It’s now being tested to treat dozens of inherited diseases, with companies planning to ask regulators for approval of the first CRISPR-based medicine as soon as later this year. At STAT, our award-winning journalists provide readers with indispensable insights and in-depth coverage of the myriad developments in CRISPR research. You can access subscriber-only articles and our exclusive data tool, CRISPR Trackr, with STAT+, our premium subscription service. On this World CRISPR Day, get your first 3 months for $30 and stay up-to-date on all things CRISPR research. Subscribe STAT's CRISPR Trackr A curated collection of methods, milestones, and discoveries that we at STAT believe represent a key advance in either the genome-editing technology or its application toward treating human disease. Learn More Latest CRISPR Coverage Biotech turns to new and strange viruses to overcome gene therapy’s limitations by Jason Mast New CRISPR startup, drawing big-name backers, seeks to fix diseases caused by large DNA errors by Allison DeAngelis After early wins, CRISPR gene editing is about to get a lot harder by Jason Mast The Readout Loud — Listen: Biden’s Covid declaration, twilight of the SPAC, & genome editing 2.0 by Damian Garde, Allison DeAngelis, and Adam Feuerstein Subscribe Now Friday, October 21, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT Plus promotional emails Contact Us